Biolife Solutions (BLFS) Return on Capital Employed (2011 - 2026)
Biolife Solutions (BLFS) reported Return on Capital Employed of 3.99% for Q1 2026, down 353.0% year-over-year from 1.58% in Q1 2025, and up 5.61% on a QoQ basis from 4.22% in Q4 2025.
Biolife Solutions (BLFS) has 16 years of Return on Capital Employed data on file, last reported at 3.99% in Q1 2026.
- Quarterly Return on Capital Employed fell 353.0% year-over-year to 3.99% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.99% (down 353.0% YoY) and the FY2025 annual result came in at 4.37%, down 317.0% from the prior year.
- Return on Capital Employed advanced to 3.99% in Q1 2026 per BLFS's latest filing, from 4.22% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 13.59% in Q2 2023 and bottomed at 26.14% in Q3 2022.
- The 5-year median for Return on Capital Employed is 3.22% (2024), against an average of 3.62%.
- The widest annual swing landed in 2022, when Return on Capital Employed sank 2176 bps; it then soared 3948 bps in 2023.
- Tracing BLFS's Return on Capital Employed over 5 years: stood at 1.4% in 2022, then sank by 330 bps to 6.0% in 2023, then jumped by 79 bps to 1.25% in 2024, then slumped by 238 bps to 4.22% in 2025, then climbed by 6 bps to 3.99% in 2026.
- Per Business Quant, the three latest BLFS Return on Capital Employed figures stand at 3.99% (Q1 2026), 4.22% (Q4 2025), and 4.6% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 5.02% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 25.95% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 18.63% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 19.44% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 6.60% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 12.74% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 13.02% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 12.04% |
| 10 | Biolife Solutions | 1.20 Bn | 1.12 Bn | 17.50 Mn | -3.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.99% |
| Dec 31, 2025 | -4.22% |
| Sep 30, 2025 | -4.60% |
| Jun 30, 2025 | -4.69% |
| Mar 31, 2025 | -0.45% |
| Dec 31, 2024 | -1.25% |
| Sep 30, 2024 | 3.61% |
| Jun 30, 2024 | -0.71% |
| Mar 31, 2024 | -3.22% |
| Dec 31, 2023 | -6.00% |
| Sep 30, 2023 | 13.34% |
| Jun 30, 2023 | 13.59% |
| Mar 31, 2023 | -2.88% |
| Dec 31, 2022 | -1.40% |
| Sep 30, 2022 | -26.14% |
| Jun 30, 2022 | -24.23% |
| Mar 31, 2022 | -8.24% |
| Dec 31, 2021 | -6.84% |
| Sep 30, 2021 | -4.38% |
| Jun 30, 2021 | -3.49% |
| Mar 31, 2021 | -3.43% |
| Dec 31, 2020 | -3.12% |
| Sep 30, 2020 | -1.09% |
| Jun 30, 2020 | -1.15% |
| Mar 31, 2020 | -0.61% |
| Dec 31, 2019 | 0.32% |
| Sep 30, 2019 | 3.54% |
| Dec 31, 2018 | 7.96% |
| Sep 30, 2018 | 7.59% |
| Dec 31, 2017 | -9.50% |
| Sep 30, 2017 | -19.30% |
| Jun 30, 2017 | -34.29% |
| Mar 31, 2017 | -53.27% |
| Dec 31, 2016 | -59.07% |
| Sep 30, 2016 | -78.24% |
| Jun 30, 2016 | -68.90% |
| Mar 31, 2016 | -53.00% |
| Dec 31, 2015 | -45.31% |
| Mar 31, 2015 | -27.75% |
| Mar 31, 2014 | -9.84% |
| Jun 30, 2013 | -17.30% |
| Mar 31, 2013 | -31.34% |
| Dec 31, 2012 | -48.86% |
| Sep 30, 2012 | -47.61% |
| Jun 30, 2012 | -67.77% |
| Mar 31, 2012 | -86.72% |
| Dec 31, 2011 | -117.00% |
| Sep 30, 2011 | -131.18% |